title: Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
authors.affiliation: Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Chesebro
authors.forename: V
authors.initials: V
authors.lastname: Toschi
authors.forename: M
authors.initials: M
authors.lastname: Lettino
authors.forename: R
authors.initials: R
authors.lastname: Gallo
authors.forename: J J
authors.initials: JJ
authors.lastname: Badimon
authors.forename: J T
authors.initials: JT
authors.lastname: Fallon
authors.forename: V
authors.initials: V
authors.lastname: Fuster
mesh_terms: D000328:Adult; D017130:Angioplasty / Q000009:adverse effects; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000990:Antithrombin III / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D003328:Coronary Thrombosis / Q000209:etiology / Q000628:therapy; D005342:Fibrinolysis; D006331:Heart Diseases / Q000209:etiology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000990:Antithrombin III; D013917:Thrombin; D001241:Aspirin